Potentials of brentuximab vedotin in the treatment of relapse/refractory cutaneous T-cell lymphomas: literature review and authors’ observation

by L. G. Gorenkova, S. K. Kravchenko, I. E. Belousova
Published 2019-07-01

Successful sequential immune epigenetic therapy of erythrodermic mycosis fungoidesessful sequential immune epigenetic therapy with the resistant course of erythrodermic mycosis fun...

by L. G. Gorenkova, S. K. Kravchenko, A. M. Kovrigina, O. A. Kolomeitsev
Published 2018-08-01

CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospe...

by A U Magomedova, A E Misyurina, J K Mangasarova, L G Gorenkova, O V Margolin, E A Fastova, S K Kravchenko
Published 2019-07-01

EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA

by Ya. K. Mangasarova, A. U. Magomedova, A. M. Kovrigina, I. E. Kostina, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, O. V. Margolin, S. K. Kravchenko
Published 2018-05-01

SUCCESSFUL USE OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF PROGRESSIVE PERIPHERAL UNSPECIFIED T-CELL LYMPHOMA IN AN ELDERLY FEMALE PATIENT

by L. G. Gorenkova, S. K. Kravchenko, E. E. Klebanova, K. I. Danishyan, M. A. Silaev, A. M. Kovrigina, N. V. Rizikova, N. I. Skidan, M. A. Ceitlina, V. G. Savchenko
Published 2017-06-01

New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas

by Irina V. Poddubnaya, Vadim V. Ptushkin, Irena E. Belousova, L. G. Gorenkova, Kamil D. Kaplanov, A. E. Karamova, Alla M. Kovrigina, O. A. Kolomeitsev, T. S. Konstantinova, Muza M. Kokhan, Tatyana I. Pospelova
Published 2020-07-01